Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles
The DOI matches its Crossref record, with a small difference in title or year; 12 of the 12 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After a 60-min chase, however, we observed a 40% loss in 22C11 labelling in control and Bin1-depleted cells, consistent with APP degradation in the lysosome (Figs 2D and E, and EV3C and D) [55,56].”
From Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid (2017) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965 · cited 1×
“About 6%, of all AD cases are caused by autosomal dominant mutations in either APP itself or in Presenilins (PSEN1 and PSEN2) (St George-Hyslop and Petit, 2005), which are key components of a multi-molecular complex with γ-secretase activity (De Strooper, 2003).”
BackgroundThe Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 2×
“Introduction Alzheimer’s disease (AD) is the most common cause of dementia and is characterized by neurofibrillary tangles and amyloid plaque brain lesions (Selkoe and Kopan, 2003; Selkoe and Podlisny, 2002; Small and Duff, 2008).”
γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal
Hardy, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s317 · Cited by 475 · cited 2×
“, 2008) and is the primary species deposited in amyloid plaques (Hardy, 2006).”
BackgroundA stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466 · cited 1×
“Of note, mutations in this region of BRI2, which result in secretion of amyloidogenic peptides, cause two distinct autosomal dominant neurodegenerative disorders (FDD and FBD) (Vidal et al., 1999, 2000).”
BackgroundVidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080076097 · Cited by 300 · cited 1×
“Of note, mutations in this region of BRI2, which result in secretion of amyloidogenic peptides, cause two distinct autosomal dominant neurodegenerative disorders (FDD and FBD) (Vidal et al., 1999, 2000).”
BackgroundFurin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154 · cited 2×
“Immature BRI2 is processed by a convertase in the secretory pathway at the carboxyl-terminus between R243 and E244 (Kim et al., 1999; Choi et al., 2004) to generate the soluble Bri2–23 peptide and a membrane-bound mBRI2.”
BackgroundMatsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., Ghiso, J., Frangione, B., & D'Adamio, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500217200 · Cited by 141
Self-citation
Research works printed but not linked: 25
- Akiyama, 2004, Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain, Acta Neuropathol. (Berl), 107, 53, 10.1007/s00401-003-0783-1 · DOI
- Cao, 2001, A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60, Science, 293, 115, 10.1126/science.1058783 · DOI · Paper page
- Choi, 2004, Axonal transport of British and Danish amyloid peptides via secretory vesicles, FASEB J., 18, 373, 10.1096/fj.03-0730fje · DOI · Paper page
- Deleersnijder, 1996, Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins, J. Biol. Chem., 271, 19475, 10.1074/jbc.271.32.19475 · DOI · Paper page
- Ehehalt, 2003, Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts, J. Cell Biol., 160, 113, 10.1083/jcb.200207113 · DOI · Paper page
- Fuentealba, 2007, ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity, Mol. Neurodegener., 2, 14, 10.1186/1750-1326-2-14 · DOI · Paper page
- Giliberto, 2008, Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a “regulated” transcriptional role, Mol. Neurodegener., 3, 12, 10.1186/1750-1326-3-12 · DOI · Paper page
- Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat. Rev. Mol. Cell. Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
- Kaether, 2006, Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface, Traffic, 7, 408, 10.1111/j.1600-0854.2006.00396.x · DOI · Paper page
- Lee, 2000, Regulation of X11L-dependent amyloid precursor protein metabolism by XB51, a novel X11L-binding protein, J. Biol. Chem., 275, 23134, 10.1074/jbc.C000302200 · DOI
- Leissring, 2002, A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP, Proc. Natl. Acad. Sci. U.S.A, 99, 4697, 10.1073/pnas.072033799 · DOI · Paper page
- Marambaud, 2005, Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation, Genes Brain Behav., 4, 134, 10.1111/j.1601-183X.2005.00086.x · DOI · Paper page
- Matsuda, 2008, BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate, J. Neurosci., 28, 8668, 10.1523/JNEUROSCI.2094-08.2008 · DOI · Paper page
- Matsuda, 2009, BRI3 inhibits APP processing in a mechanistically distinct manner than its homologue dementia gene BRI2, J. Biol. Chem., 284, 15815, 10.1074/jbc.M109.006403 · DOI
- Passer, 2000, Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor, J. Alzheimers Dis., 2, 289, 10.3233/JAD-2000-23-408 · DOI · Paper page
- Selkoe, 2003, Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration, Annu. Rev. Neurosci., 26, 565, 10.1146/annurev.neuro.26.041002.131334 · DOI · Paper page
- Selkoe, 2002, Deciphering the genetic basis of Alzheimer's disease, Annu. Rev. Genomics Hum. Genet., 3, 67, 10.1146/annurev.genom.3.022502.103022 · DOI · Paper page
- Shankar, 2008, Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory, Nat. Med., 14, 837, 10.1038/nm1782 · DOI · Paper page
- St George-Hyslop, 2005, Molecular biology and genetics of Alzheimer's disease, C. R. Biol., 328, 119, 10.1016/j.crvi.2004.10.013 · DOI · Paper page
- Tomita, 1998, Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism, J. Biol. Chem., 273, 6277, 10.1074/jbc.273.11.6277 · DOI · Paper page
- Vetrivel, 2007, Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism, Mol. Neurodegener., 2, 4, 10.1186/1750-1326-2-4 · DOI · Paper page
- Vidal, 2001, Sequence, genomic structure and tissue expression of human BRI3, a member of the BRI gene family, Gene, 266, 95, 10.1016/S0378-1119(01)00374-2 · DOI · Paper page
- Wickham, 2005, Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin, J. Neurochem., 92, 93, 10.1111/j.1471-4159.2004.02840.x · DOI · Paper page
- Wilquet, 2004, Amyloid-beta precursor protein processing in neurodegeneration, Curr .Opin. Neurobiol., 14, 582, 10.1016/j.conb.2004.08.001 · DOI · Paper page
- Wolfe, 2007, When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep., 8, 136, 10.1038/sj.embor.7400896 · DOI · Paper page
Cited by
Biology and pathophysiology of the amyloid precursor protein
Zheng, H., & Koo, E. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-27 · Cited by 348
Proteolytic processing of Alzheimer’s β‐amyloid precursor protein
Zhang, H., Ma, Q., Zhang, Y., & Xu, H. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07519.x · Cited by 343
Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid
Ubelmann, F., Burrinha, T., Salavessa, L., Gomes, R., Ferreira, C., Moreno, N., & Guimas Almeida, C. (2017) · The EMBO Reports · doi:10.15252/embr.201642738 · Cited by 165
Tamayev, R., Matsuda, S., Arancio, O., & D'Adamio, L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100195 · Cited by 142
Self-citationTamayev, R., & D’Adamio, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-19 · Cited by 81
“These include the PSEN1/2 genes, which code for the catalytic component of the γ-secretase, and the BRI2/ITM2b gene, whose protein product BRI2 binds APP and inhibits APP processing [3-10].”
BackgroundSelf-citation
Metadata
- Authors
- Matsuda, S., Matsuda, Y., Snapp, E. L., & D’Adamio, L.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 32
- Issue
- 8
- Pages
- 1400-1408
- ISSN
- 0197-4580
- Cited by
- 62
- References
- 12
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2009.08.005
- The paper
- Matsuda, S., Matsuda, Y., Snapp, E. L., & D’Adamio, L. (2011). Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2009.08.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.